NIOBF Financials 07/16/2014 19:40:33 NioCorp Developments

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
NIOBF Financials 07/16/2014 19:40:33
NioCorp Developments Ltd.
Period Ending Jun 30, 2013 Jun 30, 2012
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses
Research and Development - -
Sales, General and Admin. 793 1,418
Non-Recurring Items 1,986 143
Other 3 4
Operating Income (2,784) (1,561)
Income From Continuing Operations
Add'l Income/Expense Items 33 (596)
Earnings Before Interest and Tax (2,749) (2,161)
Interest Expense - -
Earnings Before Tax (2,749) (2,161)
Income Tax 81 -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (2,829) (2,161)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (2,829) (2,161)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (2,829) (2,161)

NioCorp Developments Ltd. (NIOBD) Stock Research Links

NIOBD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Navigating Early Career Challenges: Strategies for Success

Updated Category News Views 159

Understanding the Challenges of Early Career Professionals As the new generation of professionals prepares to step into the workforce, they often face a variety of challenges. Recent insights from professionals reveal common hurdles that individuals might encounter early in their careers. Understanding these challenges is the first step toward successfully navigating...

Continue Reading
Pharming Takes Strategic Step with Public Offer for Abliva AB

Updated Category News Views 387

Pharming Sets a New Course with Strategic Acquisition Strengthening the Pipeline with a First-in-Disease Asset Pharming Group N.V. has recently made headlines with its ambitious public cash offer for Abliva AB. This strategic acquisition, valued at approximately US$66.1 million, aims to advance Pharming's late-stage pipeline significantly. At the heart of this acquisition...

Continue Reading
Golden Sun Health Tech Launches Joint Venture in Tourism Sector

Updated Category News Views 113

Golden Sun Health Technology Group Limited Ventures into Cultural Tourism Golden Sun Health Technology Group Limited, previously known as Golden Sun Education Group Limited (NASDAQ: GSUN), has made a notable step forward by launching a joint venture aimed at tapping into the cultural tourism market. Through its wholly-owned subsidiary, Shanghai Golden Sun Gongyu Education...

Continue Reading
BlackRock Municipal Income Fund Announces Merger Dates and Changes

Updated Category News Views 520

BlackRock Municipal Income Fund Transition Announcement BlackRock Municipal Income Fund, Inc. (NYSE: MUI, referred to as the “Fund”) is set to undergo an exciting transition. The Fund will change from an exchange-listed closed-end fund to an unlisted continuously-offered closed-end fund, which will conduct quarterly repurchases of its shares. This new venture will be...

Continue Reading
Understand Your Rights: Join CrowdStrike Class Action Today

Updated Category News Views 152

Understanding the CrowdStrike Holdings Class Action Attention shareholders of CrowdStrike Holdings, Inc. (NASDAQ: CRWD): If you acquired shares during the specified class period, it’s important to understand your rights regarding an ongoing class action. Recent developments have raised concerns about the company's operations, particularly in relation to its flagship...

Continue Reading